Early Life and Family Legacy
Mario Germano Giuliani, born in 1972, comes from a family deeply rooted in the pharmaceutical industry. His great-grandfather, Germano Giuliani, established the family's pharmaceutical company, Giuliani, in Milan, Italy, in 1889. The company's origins trace back to the Antica Farmacia del Lazzaretto, Milan's first pharmacy, where the first formulation of Amaro Medicinale was developed. Giuliani is a 100% Italian Pharmaceutical Company operating in the name of Innovation, Quality, Research and Integrity.
Rise to Success
The Giuliani family's wealth significantly increased through their investment in Royalty Pharma, a New York-based firm specializing in acquiring pharmaceutical royalties. Royalty Pharma went public in 2020, and Mario Giuliani's stake in the company is a key driver of his net worth. The family's long-term view on the investment in the Italian healthcare sector has been a core component of his investment strategy. Giuliani's expertise lies in long-term investment and innovation in the pharmaceutical and consumer goods sectors.
Key Business Strategies
Mario Germano Giuliani's business approach centers on preserving and growing the family's pharmaceutical legacy. This is achieved through strategic investments, with an emphasis on the development and commercialization of specialty drugs and consumer health products. He is the director of HBM Healthcare Investments AG since 2012, and has held numerous other director positions in the pharmaceutical and financial sectors. MGG Capital is the private investment company of Mario Germano Giuliani. MGG Capital supports entrepreneurs and management teams, who aspire to take their successful companies to the next level.
Philanthropy
Giuliani's philanthropy supports various community and educational initiatives. His structural contribution is tied to the successful generational transition and stable private control of a critical Italian industrial asset.
